Global Collaborators 'cunning plan' for affordable, accessible oral anti-virals - Oct 17 2022 - ASAP - Life Science News Articles

The consortium’s strategy is to create an AI-driven Structure-enabled Antiviral Platform (ASAP), using cutting-edge technology such as advanced structural biology, fragment screening, AI and machine learning, as well as computational chemistry on Folding@home, the world’s largest distributed computing platform to build a robust and open access antiviral discovery pipeline. Click to read more...

Related Keywords

New York ,United States ,Japan ,United Kingdom ,Israel ,Tel Aviv ,Brazil ,Geneva ,Genè ,Switzerland ,Japanese ,Tamas Szommer ,Daren Fearon ,Alpha Lee ,Brian Marsden ,Oleg Fedorov ,Eleanor Williams ,Centre For Medicines Discovery ,Stanford University School Of Medicine United States ,Research Informatics ,University Of Oxford ,National Institute Of Allergy ,Weizmann Institute Of Science Israel ,Antiviral Program For Pandemics ,Memorial Sloan Kettering Cancer Centre United States ,Structural Genomic Consortium ,Wellcome Trust ,Team Leader ,Fred Hutchinson Cancer Center United States ,Structure Enabled Antiviral Platform ,Palo Alto ,Antiviral Drug Discovery ,Pandemic Concern ,National Institute ,Infectious Diseases ,Antiviral Program ,Chief Scientific Officer ,Medicines Discovery ,Senior Beamline Scientist ,Diamond Light Source ,Professor Brian Marsden ,Consistentx Ray ,Diamond Synchrotron ,Memorial Sloan Kettering Cancer Centre ,Weizmann Institute ,Mount Sinai ,Stanford University School ,Fred Hutchinson Cancer Center ,Neglected Diseases ,Yasap ,Discovery ,Drug ,Crystallisation ,Work ,Moonshot ,Science ,Targets ,Fragment ,Protein ,